Cardiovascular effects of estrogen and lipid-lowering therapies in postmenopausal women.
Guetta
V
V
Cardiology Branch, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD 20892-1650, USA.
Cannon
R O
RO
D000975:Antioxidants / Q000494:pharmacology; D003331:Coronary Vessels / Q000187:drug effects; D004967:Estrogens / Q000494:pharmacology*; D005260:Female; D006487:Hemostasis / Q000187:drug effects; D006801:Humans; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D008074:Lipoproteins / Q000097:blood; D009569:Nitric Oxide / Q000502:physiology; D017698:Postmenopause; D011372:Progestins / Q000494:pharmacology
D000975:Antioxidants; D004967:Estrogens; D000960:Hypolipidemic Agents; D008074:Lipoproteins; D011372:Progestins; D009569:Nitric Oxide